UC REGENTS PHARMACOLOGY AND NUCLEAR MEDICINE PRACTICE GROUP is a nuclear medicine in Los Angeles, CA. The provider is a nuclear medicine specialist employs the properties of radioactive atoms and molecules in the diagnosis and treatment of disease and in research. Radiation detection and imaging instrument systems are used to detect disease as it changes the function and metabolism of normal cells, tissues and organs. A wide variety of diseases can be found in this way, usually before the structure of the organ involved by the disease can be seen to be abnormal by any other techniques. Early detection of coronary artery disease (including acute heart attack), early cancer detection and evaluation of the effect of tumor treatment, diagnosis of infection and inflammation anywhere in the body and early detection of blood clot in the lungs are all possible with these techniques. Unique forms of radioactive molecules can attack and kill cancer cells (e.g., lymphoma, thyroid cancer) or can relieve the severe pain of cancer that has spread to bone UC REGENTS PHARMACOLOGY AND NUCLEAR MEDICINE PRACTICE GROUP NPI is 1861869042. The provider is registered as an organization entity type and is a multiple single specialty group.
The provider's business location address is:
10833 LE CONTE AVE
AR105 CHS
LOS ANGELES, CA
ZIP 90095-075
Phone: (310) 794-9513
Fax: (310) 267-2538
The provider's authorized official is Sherly Mosessian .
The authorized official title is Chief Adminitrative Officer and has the following contact phone number (310) 267-1188.
The enumeration date for this NPI number is 8/24/2015 and was last updated on 8/24/2015.